Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lee

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Circulation|September 10, 2003
Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study)William F Fearon, Mamoo Nakamura, David P Lee, et al.
Circulation|November 18, 2015
Response to Letters Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease"Jennifer A Tremmel, William F Fearon, Bong-Ki Lee, et al.
Journal of the American College of Cardiology|May 14, 2003
Effect of a change in gender on coronary arterial size: a longitudinal intravascular ultrasound study in transplanted heartsNiall A Herity, Sidney Lo, David P Lee, et al.
American Heart Journal|February 7, 2012
Rationale and design of the TAXUS Libertē Post-Approval Study: examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practiceKirk N Garratt, David P Lee, Eileen M Rose, et al.
Journal of the American College of Cardiology|February 1, 2005
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devicesH M Omar Farouque, Jennifer A Tremmel, Farshad Raissi Shabari, et al.
Circulation|March 26, 2003
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trialDavid P Lee, Niall A Herity, Bonnie L Hiatt, et al.
American Heart Journal|April 29, 2008
Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantationSeema S Sinha, Michael X Pham, Randall H Vagelos, et al.
Plos One|August 30, 2022
An exploratory study to characterize the HIV testing-to-care continuum to improve outcomes for Black and Latinx residents of South Los AngelesBreann M McAndrew, Noemi Gil, David P Lee, et al.
Circulation|November 18, 2014
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placementKirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
Circulation|September 30, 2015
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement"Kirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Circulation|September 10, 2003
Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study)William F Fearon, Mamoo Nakamura, David P Lee, et al.
Circulation|November 18, 2015
Response to Letters Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease"Jennifer A Tremmel, William F Fearon, Bong-Ki Lee, et al.
Journal of the American College of Cardiology|May 14, 2003
Effect of a change in gender on coronary arterial size: a longitudinal intravascular ultrasound study in transplanted heartsNiall A Herity, Sidney Lo, David P Lee, et al.
American Heart Journal|February 7, 2012
Rationale and design of the TAXUS Libertē Post-Approval Study: examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practiceKirk N Garratt, David P Lee, Eileen M Rose, et al.
Journal of the American College of Cardiology|February 1, 2005
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devicesH M Omar Farouque, Jennifer A Tremmel, Farshad Raissi Shabari, et al.
Circulation|March 26, 2003
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trialDavid P Lee, Niall A Herity, Bonnie L Hiatt, et al.
American Heart Journal|April 29, 2008
Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantationSeema S Sinha, Michael X Pham, Randall H Vagelos, et al.
Plos One|August 30, 2022
An exploratory study to characterize the HIV testing-to-care continuum to improve outcomes for Black and Latinx residents of South Los AngelesBreann M McAndrew, Noemi Gil, David P Lee, et al.
Circulation|November 18, 2014
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placementKirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
Circulation|September 30, 2015
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement"Kirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.
Pageof 8